WDR5 high expression and its effect on tumorigenesis in leukemia

Zheng Ge; Evelyn J. Song; Yuka Imamura Kawasawa; Jianyong Li; Sinisa Dovat; Chunhua Song

doi:10.18632/oncotarget.9312

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

WDR5 high expression and its effect on tumorigenesis in leukemia

Zheng Ge, Evelyn J. Song, Yuka Imamura Kawasawa, Jianyong Li, Sinisa Dovat and Chunhua Song _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:37740-37754. https://doi.org/10.18632/oncotarget.9312

Metrics: PDF 2315 views | HTML 3040 views | ?

Abstract

Zheng Ge1,2,3, Evelyn J. Song2, Yuka Imamura Kawasawa4, Jianyong Li3, Sinisa Dovat2, Chunhua Song2

1Department of Hematology (Key Department of Jiangsu Medicine), Zhongda Hospital, Southeast University Medical School, Nanjing, Jiangsu, China

2Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA, USA

3Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Provincial Hospital, Nanjing, China

4Pennsylvania State Hershey Genome Sciences Facility, Pennsylvania State College of Medicine, Hershey, PA, USA

Correspondence to:

Chunhua Song, email: [email protected]

Sinisa Dovat, email: [email protected]

Jianyong Li, email: [email protected]

Keywords: WDR5, H3K4me3, MLL, leukemia

Received: March 16, 2016 Accepted: April 27, 2016 Published: May 12, 2016

ABSTRACT

WD repeat domain 5 (WDR5) plays an important role in various biological functions through the epigenetic regulation of gene transcription. However, the oncogenic effect of WDR5 in leukemia remains largely unknown. Here, we found WDR5 expression is increased in leukemia patients. High expression of WDR5 is associated with high risk leukemia; Patients with WDR5 and MLL1 high expression have poor complete remission rate. We further identified the global genomic binding of WDR5 in leukemic cells and found the genomic co-localization of WDR5 binding with H3K4me3 enrichment. Moreover, WDR5 knockdown by shRNA suppresses cell proliferation, induces apoptosis, inhibits the expression of WDR5 targets, and blocks the H3K4me3 enrichment on the promoter of its targets. We also observed the positive correlation of WDR5 expression with these targets in the cohort study of leukemia patients. Our data reveal that WDR5 may have oncogenic effect and WDR5-mediated H3K4 methylation plays an important role in leukemogenesis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9312

Publication Alerts

Research Papers:

WDR5 high expression and its effect on tumorigenesis in leukemia

Abstract